FOXO4-DRI 10mg Research Overview

FOXO4-DRI 10mg is offered by Ascension Peptides for qualified laboratory, analytical, and pre-clinical research use. The page is organized around product identity, research context, documentation, and related catalog navigation so researchers can evaluate the material without relying on unsupported human-use or medical claims.

FOXO4-DRI is a novel senolytic peptide developed to combat cellular senescence, a biological process where cells stop dividing and enter a state of irreversible growth arrest. These senescent cells accumulate in tissues over time and secrete a range of pro-inflammatory cytokines, chemokines, and proteases, collectively known as the Senescence-Associated Secretory Phenotype (SASP). The mechanism of action for FOXO4-DRI is highly specific. In senescent cells, the transcription factor FOXO4 is sequestered in the nucleus, where it binds to the tumor suppressor protein p53. This FOXO4-p53 interaction prevents the senescent cells from undergoing apoptosis (programmed cell death), allowing them to persist and cause damage. FOXO4-DRI is a D-Retro-Inverso peptide, a modified structure that makes it resistant to degradation by proteases, thereby increasing its stability and bioavailability in the body.

Research Context and Product Evaluation

This material may be relevant to FOXO4/p53 protein-interaction research and D-retro-inverso peptide characterization. Researchers should distinguish between biochemical or pre-clinical observations in the scientific literature and claims about human outcomes. Ascension Peptides supplies this product as a research material only; the listing is not intended to provide clinical guidance, dosing instructions, or therapeutic recommendations.

Before beginning an experiment, verify the product label, stated amount, lot or batch information, and any available analytical documentation. Researchers should also record the material used in each protocol so results can be traced back to the specific batch. Storage, preparation, and handling should follow the product documentation, the laboratory’s validated SOPs, and any requirements appropriate to the experimental method.

Quality and Analytical Documentation

Product quality should be assessed with evidence rather than marketing language alone. Where available, review the Certificates of Analysis and related analytical information for identity and purity data. Analytical results can vary by batch and method, so researchers should rely on the documentation associated with the material actually received rather than assuming that one report applies to every lot.

Ascension Peptides emphasizes clear product identification and research-only positioning across its catalog. Questions about a listing, documentation, or order details can be directed to customer support.

Related Peptides Research Products

For comparative laboratory work, researchers may also review Semax 10mg, Selank 10mg, and DSIP 10mg. These internal references are provided to make it easier to compare materials within the same research catalog rather than to imply that compounds are interchangeable.

Browse the broader Peptides collection for additional research materials in this category.

Research Use Only

This product is intended strictly for research, development, and analytical laboratory use by qualified professionals. It is not intended for human or veterinary consumption, use as a food additive, household use, or use to diagnose, treat, cure, or prevent any disease. Product information is provided for catalog identification and research context only.